CClinicalTrials.gg
CompletedNCT02035735Updated Dec 11, 2018

Interest of Narrow Band Imaging in Detection of Upper Aerodigestive Cancers

An interventional study of WL and NBI in Squamous Cell Carcinoma of Oropharynx, Squamous Cell Carcinoma of Hypopharynx and Squamous Cell Carcinoma of Larynx, sponsored by University Hospital, Toulouse. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-12-11.

Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to prospectively determine if the use of NBI endoscopy modifies the superficial extension of these tumors.

Read the detailed description

Several studies have already showed the interest of the use of NBI for the early diagnosis of malignancies of the upper aerodigestive tract. For all tumors, the most accurate evaluation of its limits is very important to perform the best strategy of treatment. If surgery seems to be the best option, surgical margins must be widely healthy. Despite the systematic transnasal flexible endoscopy with white lamp followed by laryngoscopy under general anesthesia (LGA) and tomodensitometric evaluation, surgical margins can be unhealthy (in situ carcinoma or dysplasia). We propose to evaluate if the use of the NBI could be useful to determine the superficial spread of squamous cell carcinomas in these locations.

To April 2013 to Mars 2015, all patients with a suspicion of squamous cell carcinoma of the oropharynx, hypopharynx or larynx and whom a LGA are expected, are included. The day before the LGA, two endoscopies by two different physicians were performed for each patients and recorded: the first one with white light and the second one with NBI. All results are noted on a schema. Superficial extension or synchronous lesions showed by NBI are analysed and compared with with lamp technic.

After surgery, surgical margins were evaluated and healthy margins were measured.

02

Conditions studied

  • Squamous Cell Carcinoma of Oropharynx
  • Squamous Cell Carcinoma of Hypopharynx
  • Squamous Cell Carcinoma of Larynx

Keywords

  • NBI,
  • squamous cell carcinoma,
  • pharynx, larynx, surgical margins.
03

In context

Carcinoma

6,741 studies on the registry are indexed under Carcinoma; 1,161 are open to participants now.

This study's enrollment of 93 is above the median of 45 across 5,170 interventional studies indexed under Carcinoma.

Browse Carcinoma studies →

Lead sponsor

University Hospital, Toulouse is the lead sponsor of 794 studies on the registry; 214 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients who can benefit a laryngoscopic exam under general anesthesia

Exclusion criteria

Exclusion Criteria:

  • General anesthesia contra-indications
  • Local anesthesia allergy
  • Breast-feeding period or pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
93 participants (actual)

Study arms

  • Experimental
    Videoendoscopy with WL and NBI

    The day before the laryngoscopy under general anesthesia (LGA), two endoscopies by two different physicians were performed for each patients and recorded: the first one with white light (WL) and the second one with NBI (NBI).

    Procedure: WL and NBI

Interventions

  • ProcedureWL and NBI

    For each patient with a suspicion of squamous cell carcinoma of the oropharynx, hypopharynx or larynx for whom a laryngoscopy under general anesthesia (LGA) is expected benefit the day before a transnasal endoscopy with white lamp (WL) and NBI by two different operators. Suspected mucosal abnormalities showed by one or the two technics are reported in a table wich describes the different areas of the pharynx and the larynx. During the LGA, several biopsies are performed and identified (WL and/or NBI).

06

What researchers measure

Primary outcomes

  1. Number of patients for whom superficial extension of the tumors has been increased by NBI.

    Time frame: 4 minutes

Secondary outcomes

  1. Number of tumors upstaged.

    Time frame: 4 minutes

  2. Contribution of the NBI in the diagnosis of other synchronous locations.

    Time frame: 4 minutes

  3. Contribution of the NBI in the diagnosis of pre-neoplastic lesions.

    Time frame: 4 minutes

  4. Contribution of the NBI in the evaluation of surgical margins.

    Time frame: 4 minutes

07

Study locations

1 site
  • University of Toulouse
    Toulouse, 31059, France
08

References and documents

Publications

  • Chabrillac E, Espinasse G, Lepage B, Uro-Coste E, Dupret-Bories A, De Bonnecaze G, Vergez S. Contribution of narrow band imaging in delineation of laryngopharyngeal superficial cancer spread: a prospective study. Eur Arch Otorhinolaryngol. 2021 May;278(5):1491-1497. doi: 10.1007/s00405-020-06499-2. Epub 2021 Jan 5. PubMed 33398548 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02035735
Lead sponsor
University Hospital, Toulouse
Responsible party
Sponsor
First posted
Jan 14, 2014
Start date
Jan 2014
Primary completion
Oct 2017
Completion
Oct 2017
Last update
Dec 11, 2018

Study contacts

Sébastien VERGEZ, MD, PhD
principal investigator · University Hospital of Toulouse

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion